University of Milan-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2021

  1. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

    ESMO Open

2019

  1. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

2017

  1. Dual modulation of MCL-1 and mTOR determines the response to sunitinib

    Journal of Clinical Investigation, Vol. 127, Núm. 1, pp. 153-168

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508